• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RCE 6.12% 46.0¢

RECCE PHARMACEUTICALS LTD

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce... An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.More

Corporate Spotlight

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight arrow Created with Sketch.

RCE receives Indonesian approval for Phase 3 trial

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RCE 21/01/25 5 1.7K
21/01/25 Last post  BelowAverage Comments Created with Sketch.  5  Views Created with Sketch.  1.7K 
RCE 20/01/25 50 21K
20/01/25 Last post  Rykster Comments Created with Sketch.  50  Views Created with Sketch.  21K 
RCE
[INTERVIEW] Recce Pharmaceuticals Phase 3 Diabetic Foot Infection Trial fast-tracked, thanks to Indonesian approval
09/12/24 0 435
09/12/24 Last post  TheMarketOnline Comments Created with Sketch.  0  Views Created with Sketch.  435 
RCE 08/12/24 28 9.7K
08/12/24 Last post  bcr Comments Created with Sketch.  28  Views Created with Sketch.  9.7K 
RCE 03/12/24 10 3.5K
03/12/24 Last post  BC1954 Comments Created with Sketch.  10  Views Created with Sketch.  3.5K 
RCE 29/11/24 3 1.7K
29/11/24 Last post  Bpharma Comments Created with Sketch.  3  Views Created with Sketch.  1.7K 
RCE 26/11/24 5 2.0K
26/11/24 Last post  Rykster Comments Created with Sketch.  5  Views Created with Sketch.  2.0K 
RCE 21/11/24 1 628
21/11/24 Last post  ToiletPaper Comments Created with Sketch.  1  Views Created with Sketch.  628 
RCE 21/11/24 16 5.5K
21/11/24 Last post  ToiletPaper Comments Created with Sketch.  16  Views Created with Sketch.  5.5K 
RCE 15/11/24 1 846
15/11/24 Last post  Trader36 Comments Created with Sketch.  1  Views Created with Sketch.  846 
RCE 13/11/24 0 405
13/11/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  405 
RCE 12/11/24 20 7.8K
12/11/24 Last post  BelowAverage Comments Created with Sketch.  20  Views Created with Sketch.  7.8K 
RCE 12/11/24 7 3.7K
12/11/24 Last post  BelowAverage Comments Created with Sketch.  7  Views Created with Sketch.  3.7K 
RCE 06/11/24 0 449
06/11/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  449 
RCE 06/11/24 0 428
06/11/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  428 
RCE 06/11/24 9 3.2K
06/11/24 Last post  Rykster Comments Created with Sketch.  9  Views Created with Sketch.  3.2K 

See All Discussions arrow Created with Sketch.

Corporate Spotlight

Timeline

Patient Dosing Complete in Phase II ABSSSI Trial of R327G
21 Jan 09:57
 
Regulatory Approval for Registrational Phase 3 R327G Trial
09 Dec 09:05
 
Trading Halt
05 Dec 09:21
 
Presentation - Ord Minnett Biotech & MedTech Conference
28 Nov 12:42
 
Australia Patent Granted for RECCE Anti-Infectives
26 Nov 08:37
 
Change of Director's Interest Notices
21 Nov 19:31
 
View More arrow Created with Sketch.
(20min delay)
Last
46.0¢
Change
-0.030(6.12%)
Mkt cap ! $106.6M
Open High Low Value Volume
49.0¢ 49.0¢ 46.0¢ $19.48K 40.43K

Buyers (Bids)

No. Vol. Price($)
3 26492 46.0¢
 

Sellers (Offers)

Price($) Vol. No.
48.5¢ 15359 2
View Market Depth
Last trade - 16.10pm 23/01/2025 (20 minute delay) ?
Last
47.0¢
  Change
-0.030 ( 3.09 %)
Open High Low Volume
48.0¢ 48.0¢ 47.0¢ 10500
Last updated 15.56pm 23/01/2025 ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.